Clinical Lab Products: All Press Releaseshttp://www.clpmag.com/prnewswire/All unedited Press Releasesen-usThu, 11 Mar 2010 19:03 ESTThu, 11 Mar 2010 19:03 ESTbioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Toolhttp://www.clpmag.com/press_release.asp?id=10232588Thu, 11 Mar 2010 19:03 ESThttp://www.clpmag.com/press_release.asp?id=10232588Effort Aims to Spike Breast Cancer With New Approachhttp://www.clpmag.com/press_release.asp?id=10232587Thu, 11 Mar 2010 17:58 ESThttp://www.clpmag.com/press_release.asp?id=10232587Microchip Biotechnologies Changes Name to IntegenXhttp://www.clpmag.com/press_release.asp?id=10232579Thu, 11 Mar 2010 14:51 ESThttp://www.clpmag.com/press_release.asp?id=10232579Clarient Reports 2009 Fourth Quarter; Year-End Resultshttp://www.clpmag.com/press_release.asp?id=10232538Wed, 10 Mar 2010 21:15 ESThttp://www.clpmag.com/press_release.asp?id=10232538CardioGenics Announces Further Update Regarding Status of Merck Agreementhttp://www.clpmag.com/press_release.asp?id=10232521Wed, 10 Mar 2010 15:51 ESThttp://www.clpmag.com/press_release.asp?id=10232521Vermillion Announces Scientific Advisory Board Appointmentshttp://www.clpmag.com/press_release.asp?id=10232498Wed, 10 Mar 2010 13:08 ESThttp://www.clpmag.com/press_release.asp?id=10232498The Side-Out Foundation Hopes to Score Big with Its First Funded Breast Cancer Clinical Trialhttp://www.clpmag.com/press_release.asp?id=10232432Tue, 9 Mar 2010 14:00 ESThttp://www.clpmag.com/press_release.asp?id=10232432Caliper Life Sciences Reports Fourth Quarter and Full Year 2009 Resultshttp://www.clpmag.com/press_release.asp?id=10232403Tue, 9 Mar 2010 13:26 ESThttp://www.clpmag.com/press_release.asp?id=10232403OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancerhttp://www.clpmag.com/press_release.asp?id=10232402Tue, 9 Mar 2010 13:06 ESThttp://www.clpmag.com/press_release.asp?id=10232402Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitorshttp://www.clpmag.com/press_release.asp?id=10232384Mon, 8 Mar 2010 21:34 ESThttp://www.clpmag.com/press_release.asp?id=10232384Sequenom Announces Date of Full Year 2009 Financial Results and Conference Callhttp://www.clpmag.com/press_release.asp?id=10232383Mon, 8 Mar 2010 21:00 ESThttp://www.clpmag.com/press_release.asp?id=10232383Reportlinker Adds Global Nanobiotechnology Industryhttp://www.clpmag.com/press_release.asp?id=10232364Mon, 8 Mar 2010 15:55 ESThttp://www.clpmag.com/press_release.asp?id=10232364Reportlinker Adds Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends)http://www.clpmag.com/press_release.asp?id=10232363Mon, 8 Mar 2010 14:38 ESThttp://www.clpmag.com/press_release.asp?id=10232363ThermalTherapeutic Systems Announces FDA Clearance of the VERATHERM(TM) Portable Hyperthermic Perfusion Systemhttp://www.clpmag.com/press_release.asp?id=10232349Mon, 8 Mar 2010 12:20 ESThttp://www.clpmag.com/press_release.asp?id=10232349Clarient CEO Ron Andrews to Present at the Roth Annual OC Growth Stock Conference in Dana Point, CAhttp://www.clpmag.com/press_release.asp?id=10232348Mon, 8 Mar 2010 11:00 ESThttp://www.clpmag.com/press_release.asp?id=10232348China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010http://www.clpmag.com/press_release.asp?id=10232304Fri, 5 Mar 2010 11:00 ESThttp://www.clpmag.com/press_release.asp?id=10232304Quest Diagnostics and Surescripts to Pioneer Integrated Service Combining Lab and Prescription Information to Improve Patient Safety and Clinical Outcomeshttp://www.clpmag.com/press_release.asp?id=10232236Thu, 4 Mar 2010 13:30 ESThttp://www.clpmag.com/press_release.asp?id=10232236Sequenom to Present at Two Financial Conferences in Marchhttp://www.clpmag.com/press_release.asp?id=10232218Wed, 3 Mar 2010 21:00 ESThttp://www.clpmag.com/press_release.asp?id=10232218Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapyhttp://www.clpmag.com/press_release.asp?id=10232207Wed, 3 Mar 2010 17:00 ESThttp://www.clpmag.com/press_release.asp?id=10232207Bozeman Deaconess Hospital Joins Seattle Cancer Care Alliance Affiliate Networkhttp://www.clpmag.com/press_release.asp?id=10232208Wed, 3 Mar 2010 17:00 ESThttp://www.clpmag.com/press_release.asp?id=10232208